FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:APP-SEC63 (FusionGDB2 ID:5776)

Fusion Gene Summary for APP-SEC63

check button Fusion gene summary
Fusion gene informationFusion gene name: APP-SEC63
Fusion gene ID: 5776
HgeneTgene
Gene symbol

APP

SEC63

Gene ID

351

11231

Gene nameamyloid beta precursor proteinSEC63 homolog, protein translocation regulator
SynonymsAAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2|preA4DNAJC23|ERdj2|PCLD2|PRO2507|SEC63L
Cytomap

21q21.3

6q21

Type of geneprotein-codingprotein-coding
Descriptionamyloid-beta precursor proteinalzheimer disease amyloid proteinamyloid beta (A4) precursor proteinamyloid beta A4 proteinamyloid precursor proteinbeta-amyloid peptidebeta-amyloid peptide(1-40)beta-amyloid peptide(1-42)beta-amyloid precursor proteitranslocation protein SEC63 homologSEC63 protein translocation regulatorSEC63-like protein
Modification date2020032920200313
UniProtAcc

P05067

.
Ensembl transtripts involved in fusion geneENST00000346798, ENST00000354192, 
ENST00000348990, ENST00000357903, 
ENST00000358918, ENST00000359726, 
ENST00000448388, ENST00000440126, 
ENST00000439274, ENST00000474136, 
ENST00000369002, ENST00000460009, 
Fusion gene scores* DoF score31 X 25 X 12=930038 X 14 X 15=7980
# samples 3339
** MAII scorelog2(33/9300*10)=-4.81669278663694
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(39/7980*10)=-4.3548427173601
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: APP [Title/Abstract] AND SEC63 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointAPP(27252862)-SEC63(108214782), # samples:1
Anticipated loss of major functional domain due to fusion event.APP-SEC63 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneAPP

GO:0001934

positive regulation of protein phosphorylation

11404397

HgeneAPP

GO:0008285

negative regulation of cell proliferation

22944668

HgeneAPP

GO:1905606

regulation of presynapse assembly

19726636


check buttonFusion gene breakpoints across APP (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across SEC63 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4THCATCGA-DJ-A13S-01AAPPchr21

27252862

-SEC63chr6

108214782

-


Top

Fusion Gene ORF analysis for APP-SEC63

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000346798ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000346798ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
Frame-shiftENST00000354192ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000354192ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
Frame-shiftENST00000348990ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000348990ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
Frame-shiftENST00000357903ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000357903ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
In-frameENST00000358918ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000358918ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
In-frameENST00000359726ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
5CDS-intronENST00000359726ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
intron-3CDSENST00000448388ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
intron-intronENST00000448388ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
intron-3CDSENST00000440126ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
intron-intronENST00000440126ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
intron-3CDSENST00000439274ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
intron-intronENST00000439274ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-
intron-3CDSENST00000474136ENST00000369002APPchr21

27252862

-SEC63chr6

108214782

-
intron-intronENST00000474136ENST00000460009APPchr21

27252862

-SEC63chr6

108214782

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000358918APPchr2127252862-ENST00000369002SEC63chr6108214782-823235782002458752
ENST00000359726APPchr2127252862-ENST00000369002SEC63chr6108214782-811834642002344714

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000358918ENST00000369002APPchr2127252862-SEC63chr6108214782-0.0004206230.99957937
ENST00000359726ENST00000369002APPchr2127252862-SEC63chr6108214782-0.0004690410.99953103

Top

Fusion Genomic Features for APP-SEC63


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for APP-SEC63


check button Go to

FGviewer for the breakpoints of chr21:27252862-chr6:108214782

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
APP

P05067

.
FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapes in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. {ECO:0000250, ECO:0000250|UniProtKB:P12023, ECO:0000269|PubMed:17062754, ECO:0000269|PubMed:23011729, ECO:0000269|PubMed:25122912}.; FUNCTION: Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.; FUNCTION: Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain. {ECO:0000250}.; FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.; FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818230_2601144.3333333333333771.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818274_2801144.3333333333333771.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616230_2601069.3333333333333696.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616274_2801069.3333333333333696.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515230_2601013.3333333333334640.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515274_2801013.3333333333334640.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717230_2601125.3333333333333752.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717274_2801125.3333333333333752.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717230_2601126.0753.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717274_2801126.0753.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717230_2601088.0715.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717274_2801088.0715.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-181828_1891144.3333333333333771.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818374_5651144.3333333333333771.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-161628_1891069.3333333333333696.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616374_5651069.3333333333333696.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-151528_1891013.3333333333334640.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515374_5651013.3333333333334640.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-171728_1891125.3333333333333752.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717374_5651125.3333333333333752.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-171728_1891126.0753.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717374_5651126.0753.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-171728_1891088.0715.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717374_5651088.0715.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818344_3651144.3333333333333771.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818724_7341144.3333333333333771.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616344_3651069.3333333333333696.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616724_7341069.3333333333333696.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515344_3651013.3333333333334640.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515724_7341013.3333333333334640.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717344_3651125.3333333333333752.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717724_7341125.3333333333333752.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717344_3651126.0753.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717724_7341126.0753.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717344_3651088.0715.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717724_7341088.0715.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818131_1891144.3333333333333771.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818181_1881144.3333333333333771.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-181828_1231144.3333333333333771.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818391_4231144.3333333333333771.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818491_5221144.3333333333333771.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818523_5401144.3333333333333771.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-181896_1101144.3333333333333771.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616131_1891069.3333333333333696.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616181_1881069.3333333333333696.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-161628_1231069.3333333333333696.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616391_4231069.3333333333333696.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616491_5221069.3333333333333696.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616523_5401069.3333333333333696.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-161696_1101069.3333333333333696.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515131_1891013.3333333333334640.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515181_1881013.3333333333334640.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-151528_1231013.3333333333334640.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515391_4231013.3333333333334640.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515491_5221013.3333333333334640.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515523_5401013.3333333333334640.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-151596_1101013.3333333333334640.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717131_1891125.3333333333333752.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717181_1881125.3333333333333752.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-171728_1231125.3333333333333752.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717391_4231125.3333333333333752.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717491_5221125.3333333333333752.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717523_5401125.3333333333333752.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-171796_1101125.3333333333333752.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717131_1891126.0753.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717181_1881126.0753.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-171728_1231126.0753.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717391_4231126.0753.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717491_5221126.0753.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717523_5401126.0753.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-171796_1101126.0753.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717131_1891088.0715.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717181_1881088.0715.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-171728_1231088.0715.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717391_4231088.0715.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717491_5221088.0715.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717523_5401088.0715.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-171796_1101088.0715.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-181818_7011144.3333333333333771.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818723_7701144.3333333333333771.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-161618_7011069.3333333333333696.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616723_7701069.3333333333333696.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-151518_7011013.3333333333334640.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515723_7701013.3333333333334640.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-171718_7011125.3333333333333752.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717723_7701125.3333333333333752.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-171718_7011126.0753.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717723_7701126.0753.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-171718_7011088.0715.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717723_7701088.0715.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818702_7221144.3333333333333771.0TransmembraneHelical
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616702_7221069.3333333333333696.0TransmembraneHelical
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515702_7221013.3333333333334640.0TransmembraneHelical
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717702_7221125.3333333333333752.0TransmembraneHelical
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717702_7221126.0753.0TransmembraneHelical
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717702_7221088.0715.0TransmembraneHelical
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021597_6350761.0Coiled coilOntology_term=ECO:0000255
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021734_7600761.0Compositional biasNote=Asp/Glu-rich (highly acidic)
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021104_1650761.0DomainJ
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021197_5410761.0DomainNote=SEC63 1
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021637_7140761.0DomainNote=SEC63 2
TgeneSEC63chr21:27252862chr6:108214782ENST000003690020211_140761.0Topological domainLumenal
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021210_7600761.0Topological domainCytoplasmic
TgeneSEC63chr21:27252862chr6:108214782ENST0000036900202136_690761.0Topological domainCytoplasmic
TgeneSEC63chr21:27252862chr6:108214782ENST0000036900202191_1880761.0Topological domainLumenal
TgeneSEC63chr21:27252862chr6:108214782ENST0000036900202115_350761.0TransmembraneHelical
TgeneSEC63chr21:27252862chr6:108214782ENST00000369002021189_2090761.0TransmembraneHelical
TgeneSEC63chr21:27252862chr6:108214782ENST0000036900202170_900761.0TransmembraneHelical

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117230_2600747.0Compositional biasNote=Asp/Glu-rich (acidic)
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117274_2800747.0Compositional biasNote=Poly-Thr
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-11728_1890747.0DomainE1
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117374_5650747.0DomainE2
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117344_3650747.0MotifOX-2
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117724_7340747.0MotifNote=Basolateral sorting signal
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117131_1890747.0RegionCuBD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117181_1880747.0RegionNote=Zinc-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-11728_1230747.0RegionGFLD subdomain
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117391_4230747.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117491_5220747.0RegionNote=Heparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117523_5400747.0RegionCollagen-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-11796_1100747.0RegionHeparin-binding
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-11718_7010747.0Topological domainExtracellular
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117723_7700747.0Topological domainCytoplasmic
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117702_7220747.0TransmembraneHelical


Top

Fusion Gene Sequence for APP-SEC63


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>In-frame_ENST00000358918_ENST00000369002_TCGA-DJ-A13S-01A_APP_chr21_27252862_-_SEC63_chr6_108214782_length(transcript)=8232nt_BP=3578nt
GGATCAGCTGACTCGCCTGGCTCTGAGCCCCGCCGCCGCGCTCGGGCTCCGTCAGTTTCCTCGGCAGCGGTAGGCGAGAGCACGCGGAGG
AGCGTGCGCGGGGGCCCCGGGAGACGGCGGCGGTGGCGGCGCGGGCAGAGCAAGGACGCGGCGGATCCCACTCGCACAGCAGCGCACTCG
GTGCCCCGCGCAGGGTCGCGATGCTGCCCGGTTTGGCACTGCTCCTGCTGGCCGCCTGGACGGCTCGGGCGCTGGAGGTACCCACTGATG
GTAATGCTGGCCTGCTGGCTGAACCCCAGATTGCCATGTTCTGTGGCAGACTGAACATGCACATGAATGTCCAGAATGGGAAGTGGGATT
CAGATCCATCAGGGACCAAAACCTGCATTGATACCAAGGAAGGCATCCTGCAGTATTGCCAAGAAGTCTACCCTGAACTGCAGATCACCA
ATGTGGTAGAAGCCAACCAACCAGTGACCATCCAGAACTGGTGCAAGCGGGGCCGCAAGCAGTGCAAGACCCATCCCCACTTTGTGATTC
CCTACCGCTGCTTAGTTGGTGAGTTTGTAAGTGATGCCCTTCTCGTTCCTGACAAGTGCAAATTCTTACACCAGGAGAGGATGGATGTTT
GCGAAACTCATCTTCACTGGCACACCGTCGCCAAAGAGACATGCAGTGAGAAGAGTACCAACTTGCATGACTACGGCATGTTGCTGCCCT
GCGGAATTGACAAGTTCCGAGGGGTAGAGTTTGTGTGTTGCCCACTGGCTGAAGAAAGTGACAATGTGGATTCTGCTGATGCGGAGGAGG
ATGACTCGGATGTCTGGTGGGGCGGAGCAGACACAGACTATGCAGATGGGAGTGAAGACAAAGTAGTAGAAGTAGCAGAGGAGGAAGAAG
TGGCTGAGGTGGAAGAAGAAGAAGCCGATGATGACGAGGACGATGAGGATGGTGATGAGGTAGAGGAAGAGGCTGAGGAACCCTACGAAG
AAGCCACAGAGAGAACCACCAGCATTGCCACCACCACCACCACCACCACAGAGTCTGTGGAAGAGGTGGTTCGAGAGGTGTGCTCTGAAC
AAGCCGAGACGGGGCCGTGCCGAGCAATGATCTCCCGCTGGTACTTTGATGTGACTGAAGGGAAGTGTGCCCCATTCTTTTACGGCGGAT
GTGGCGGCAACCGGAACAACTTTGACACAGAAGAGTACTGCATGGCCGTGTGTGGCAGCGCCATGTCCCAAAGTTTACTCAAGACTACCC
AGGAACCTCTTGCCCGAGATCCTGTTAAACTTCCTACAACAGCAGCCAGTACCCCTGATGCCGTTGACAAGTATCTCGAGACACCTGGGG
ATGAGAATGAACATGCCCATTTCCAGAAAGCCAAAGAGAGGCTTGAGGCCAAGCACCGAGAGAGAATGTCCCAGGTCATGAGAGAATGGG
AAGAGGCAGAACGTCAAGCAAAGAACTTGCCTAAAGCTGATAAGAAGGCAGTTATCCAGCATTTCCAGGAGAAAGTGGAATCTTTGGAAC
AGGAAGCAGCCAACGAGAGACAGCAGCTGGTGGAGACACACATGGCCAGAGTGGAAGCCATGCTCAATGACCGCCGCCGCCTGGCCCTGG
AGAACTACATCACCGCTCTGCAGGCTGTTCCTCCTCGGCCTCGTCACGTGTTCAATATGCTAAAGAAGTATGTCCGCGCAGAACAGAAGG
ACAGACAGCACACCCTAAAGCATTTCGAGCATGTGCGCATGGTGGATCCCAAGAAAGCCGCTCAGATCCGGTCCCAGGTTATGACACACC
TCCGTGTGATTTATGAGCGCATGAATCAGTCTCTCTCCCTGCTCTACAACGTGCCTGCAGTGGCCGAGGAGATTCAGGATGAAGTTGATG
AGCTGCTTCAGAAAGAGCAAAACTATTCAGATGACGTCTTGGCCAACATGATTAGTGAACCAAGGATCAGTTACGGAAACGATGCTCTCA
TGCCATCTTTGACCGAAACGAAAACCACCGTGGAGCTCCTTCCCGTGAATGGAGAGTTCAGCCTGGACGATCTCCAGCCGTGGCATTCTT
TTGGGGCTGACTCTGTGCCAGCCAACACAGAAAACGAAGGTTCTGGGTTGACAAATATCAAGACGGAGGAGATCTCTGAAGTGAAGATGG
ATGCAGAATTCCGACATGACTCAGGATATGAAGTTCATCATCAAAAATTGGTGTTCTTTGCAGAAGATGTGGGTTCAAACAAAGGTGCAA
TCATTGGACTCATGGTGGGCGGTGTTGTCATAGCGACAGTGATCGTCATCACCTTGGTGATGCTGAAGAAGAAACAGTACACATCCATTC
ATCATGGTGTGGTGGAGGTTGACGCCGCTGTCACCCCAGAGGAGCGCCACCTGTCCAAGATGCAGCAGAACGGCTACGAAAATCCAACCT
ACAAGTTCTTTGAGCAGATGCAGAACTAGACCCCCGCCACAGCAGCCTCTGAAGTTGGACAGCAAAACCATTGCTTCACTACCCATCGGT
GTCCATTTATAGAATAATGTGGGAAGAAACAAACCCGTTTTATGATTTACTCATTATCGCCTTTTGACAGCTGTGCTGTAACACAAGTAG
ATGCCTGAACTTGAATTAATCCACACATCAGTAATGTATTCTATCTCTCTTTACATTTTGGTCTCTATACTACATTATTAATGGGTTTTG
TGTACTGTAAAGAATTTAGCTGTATCAAACTAGTGCATGAATAGATTCTCTCCTGATTATTTATCACATAGCCCCTTAGCCAGTTGTATA
TTATTCTTGTGGTTTGTGACCCAATTAAGTCCTACTTTACATATGCTTTAAGAATCGATGGGGGATGCTTCATGTGAACGTGGGAGTTCA
GCTGCTTCTCTTGCCTAAGTATTCCTTTCCTGATCACTATGCATTTTAAAGTTAAACATTTTTAAGTATTTCAGATGCTTTAGAGAGATT
TTTTTTCCATGACTGCATTTTACTGTACAGATTGCTGCTTCTGCTATATTTGTGATATAGGAATTAAGAGGATACACACGTTTGTTTCTT
CGTGCCTGTTTTATGTGCACACATTAGGCATTGAGACTTCAAGCTTTTCTTTTTTTGTCCACGTATCTTTGGGTCTTTGATAAAGAAAAG
AATCCCTGTTCATTGTAAGCACTTTTACGGGGCGGGTGGGGAGGGGTGCTCTGCTGGTCTTCAATTACCAAGAATTCTCCAAAACAATTT
TCTGCAGGATGATTGTACAGAATCATTGCTTATGACATGATCGCTTTCTACACTGTATTACATAAATAAATTAAATAAAATAACCCCGGG
CAAGACTTTTCTTTGAAGGATGACTACAGACATTAAATAATCGAAGTAATTTTGGGTGGGGAGAAGAGGCAGATTCAATTTTCTTTAACC
AGTCTGAAGTTTCATTTATGATACAAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGGATGAGGAAGGCATGCCTGGACAAACCCTTC
TTTTAAGATGTGTCTTCAATTTGTATAAAATGGTGTTTTCATGTAAATAAATACATTCTTGGAGGAGCTTGGAAGTTCATGAGGCTAAGC
CTGTGCCAGAAAATCACCCACAGTGGGATACAGCAATAGAGGGGGATGAAGACCAGGAGGACAGTGAGGGCTTTGAAGATAGCTTTGAGG
AAGAAGAGGAGGAAGAAGAAGATGATGACTAAGCAGTACTCTGAATGGACCACAGTGTTTGCACATATTTGCAATTTTTTGCTGTTTTGG
AAGTGTATCATAAACCAGAAACAGTACAGAACTGATGTTGAGGGAGGTGTAGTTTTTTTACTCTTGAAATGGGTGCATAATATAACTAGG
CAGTGGCGGTGCCTTGGTACAACCTGAAAAATGTTAAGGCTTATTGAAACCTTTCAAGTAGGGGATGGTACATTTATTTCATCTGCAAAT
GATAATAAATCCTTTGTTATTATAACTGTCCAGAAGTGTGGGCTATGTATTATCTGATCAGTCTATGGTCCCAGTAAAAGTAAAGATGCA
GGAAACACAGTCTGTAAATGAGCGACTTTTCTTTGTTCAGCTTTAGTTTTAGCAAACACCACAAATATGTTTTAAGTAACATCGCTCAAG
TTTAAGTAACATCGCTCAAGTTGATAATCTCTTGATAAGCTCTGTTGTTGACATTTTGCAGTGATACAACAGCTCCACTCATAGATTTAA
ACTTTTATTTTTACTTATCTTGGTCATAAGTTGGCATTCTCTCACATTCCACATGATATAGAGGGCTACGTTTTGGAATTTTCCTTTTCT
TAATTGCCCAGAGTTATCAGACAGATTATAAAAATGGCTTTTAATGGCTTAAACCATTTCTAAACCTCTATCTTAGCAGATCAATGCAGG
ATCTAATTCTTTTGATAAGTTCTAGCTCTAAAAGTGATAGTGGGACTGTATGTTTTCTGATACTGGTGGCTTATGTTATTAAACCTTTTT
TAAAAAAGGTTCACTCTAAAAGCTGAACTACATCCTTAGTTTTCAGTCTACTTGACTCTATCAGGAGCTTTTTAAGGAAAGTAAGTATAA
CATGCAAAGGAAGCTTTTTTTGTATTCATTTTGGACTCCTGTCAATAAAAATAGAAGTTTGTTGACTCGTTTTATGTTTCAATGGTGTGT
GTCTTTTTACTATCAGGACATAAATAGGGCAATCCACTTCTTTATTTTTCAACTAAAGATTGAATAGTATTGTACATTACTGCTAAAGTG
ACTGCTATTTCTGTATACTGTAGAAAAACCCAGGAGTGAGAGGGATTTCCCCTCATAGTACAACTGGAAGGATAGTGCTTGTAAAGAGTA
GAGATGTGTACATGATGAATCATTGAGGGAGGGTGGATATTTTTATTCCTAGATATGGAGGAAACATAAGTCTGTAGTATTATAAAACTG
ATTGTAATAATTCTTTCCTATCAAAATCTCCATAGGTCAAAATATTGTTGGAATACTAAAATTTGCAACCTTGTTTACTTTAAAAGGTTG
CCACTTTCAGTGCAGAATACTACCGGCATCTTGTTACTGCAATAGTTGGAAATAAAATGTGAAAATTAGCAAAACCATGAATGGTTTTTT
TGGTTCTAAATTTAAGATGTAATATTTCCTATAAAAGGGTGAAAGCAGTTTCTTTCTCTATAACCTCAATCACCAGTTTAGTGAGAGCCT
TTCTTGGCAGGCAGGAGGCAGTGTCACTGAGGATTTTTTTCATTTACTTCATTGTACAAGTAGGAGGGTGGGTTTAATTTTCAAATCAGG
TTCTGCTGTGAAGCACCAGTGTCTTGAGGCAGCTACTGATTACCTAAGTGTGGTGGCAGGGGGTAAGCCAGCTGGTGTCAAGTGAAAGGA
GGGATTAGAGAAAACAGGTGTGGCACGAAGGCAAGGAAACTGAGCAGACAAGACAGAACAATGTGTAGAATGCATATTTCCTAGTTTTCT
TGAAAGATTTCAAGAAAAGTTGTTTTTTTTTTTCTAGTGGCTACTTTGCCTTAAAGAGGCTTTATAAGTTCATTCACACAGCTGGCTTCT
CTGGTTTTAAGATTCTGGAGAGGATGATAACCTAGTAACACCACAGTGCTTAAAAAAAAAAAAAAAAAAAAAACTACCATCACCAGAAAA
TTCCACCAGTTTGTTTTCCTTTTCTCTTTGTGTGATGTGTATGTACTTCCCAACTAAGTAAAATAAAATTTCCTCTAGTGAGTGCTTTAG
GTAACCTCTTTCCATATGGCAGTAGTGAAAGAACTGAGCCTTCAGTTGATAGTTCTTCTCTCTCCAGCAAGTCGCTAAACTCCACATCCC
TTCGTTTTTCCTCTGGAATGAGAATAACAAACTATCCTAGTTTGCATTTAATCTAATGGAAACTTGAGCAAAGTTTCAATTTTCTTCCTA
TAAAGAAACTGACATTTTGTCAACAATTGATGAGCCTATAGATCATACAGTGTATAGGAAGTGAAATTGAAACAGTTAAATTATGTGATA
TTTTTCTCTAATTGGTAAAGTACCTATTAAAATACAGCTGTTCATGAGGAGACTTACCACAATTCAAAGTGTAGCAGTTGTGTATTTTAG
CATTATAATATTTGATTGAGGCCCTGAGGTGTTAATATCTCAATCTCAGAGTTAGATGTTCATGTCCTTTTTGAATTTTTTAAACATTTT
TCATAATTTTTTTTTTAAGTTAGGGAGCACATTGAGTGAAGTTCTCTGTGTAGAACAATACCTTCTGCTCTGCTTCTCCCAGCTTTCACT
GAGGGCTGGAAAAGGACAGGCCTGTCCAGCTGTACTGTCCCACTGTGTATGGGGAAGCTCAGGCTCTGGTGGAAGCAGGGGGCGTGGATG
TCAAACAACTGATGTGGAAACAGGGAGGGAGAGATATAATGAGGCTCTCTAGGCATGTTATTTTTGACCACAAGTTTTGTTCAGTTTGCT
TCAGCCAATCCAAACCATATACTAGAGTGTTCTGTAGTCACAATTCTTATTTCAAATGTAATTCAGCACCTTACATAATTTTTGAGAGGT
TGTCATTCATCACATATTTACTGAGTTTCTATGTGCCAGGCTCTGTGACTGGATACTGGAGCTATCAAAATGAAAAAAATAGTGTTAAGA
ACTCACTCGCTGGTGTTAGAGCAGGTAGATGAGTGGCAATCCATTTAAATCCATTTGCCTTGGCTATTATTTGGAATGCCTTTTTTTTTT
TTTAGTCTATCTACTGTAGGCAGAAGAATTATTTCTTTAGGGGCTAGCTGTTTATTTTGCTGGCCTTTTTTTCTCTCTTTCTCTTTTTCT
TCTTAAGACGGAGTCTCGCTCTGTCCTCCAGGCTGGAGGAGTGCAGTGGCACGATCTCAGCTCACTGCAACCTCCGCCTCCCAGCTTCAA
GCGATTCTTCTGCCTCAGCCTCCTGAGTAGCTGGGACTGCAGGTGCATGCCACCACACCCAGCTAATTTTTTAATTTTTAGTAGAGATGG
GATTTTGCCACGTTGTCCAGCCTGGTCTCGAACTCCTGGCCTCAAGTGATCAGCCCTCCTCAGCCTCCCAAAGTGCTGGCATTACAGGCA
TGAGCCACTGCGCCCAGCCTGTTGGGTTTTTTTGGAAAAAAAACAAAAACAACAAATCATCATCCTTTCCTTTAAAATGTTTTTTTTTTT
TTAAGAAACAATTTTCCCACAAACGGTCTGATTTAACTCCATGAAATCCTCTATTTAGACTGCCTTAAAGTGAAATAACTGTTGGTGAAC
CATAACATTTTGCCAGCTGTGTAGTGATTAGTCCAAATATGTCTCAAGAAGTTAGCACCAAGCATTCTCATCCATTTAAACTTGATGCTA
GGGCTATTTTGCAAAACTTAAAAAGATGCGATCTTGTACATATTTCTGTAACCTGAGCTGAAAACCCAAATAACAATCATTGACATACTT
TAGGGCTATTGTTTCAGGTGGGGGTGTATACATCCCAGGGGCGTGGAGATGATCAATCCATTGAGGAAGTATTAAGATGATTATTTGTAT
TTAATCTCATCCTTTTAAATTTCTATTTTTGTGTGTTTTATAATGTACATAATATATTGTACAATTGTACACTTCTATTATTTATAAATA
AACATTTATTGGTGCATTAAGTAGAGCTGAAGTTTCCTGCACCAGGCAAGCCTGGAAATTATCAGTATACTGTGTTTCTGAGATCAGACT
CCTATATGGGTTTGGATCAGATTAAACCATTGAAGGAAAAACAAGAATGGTGGTGGCTTTACATTGCAGATAGGAAGGAGCAGACATTAA
TATCCATGCCATATCATGTGTGTACGCTGAAAGATACAGAGGAGGAGTGGCAAGAATTACAACAAAGCATACAGCGAAAAGAGAGAGCTC
TATTGGAAACCAAATCAAAAATAACACATCCTGTGTATAGCCTTTACTTTCCTGAGGAAGCTGCAGTAAAGGAAGATGAAGAAGAAGTTT
CAGATAAGGGCAGTGATTCTGAAGAAGAAGAAACCAATAGAGATTCCCAAAGTGAGAAAGATGATGGTAGTGACAGAGACTCTGATAGAG
AGCAAGATGAAAAACAAAACAAAGATGATGAAGCAAAAAAAAAAGAAACCTTTAAAAAAAAAACCTACACCTGTGCTATTACCACAGTCA

>In-frame_ENST00000358918_ENST00000369002_TCGA-DJ-A13S-01A_APP_chr21_27252862_-_SEC63_chr6_108214782_length(amino acids)=752AA_start in transcript=200_stop in transcript=2458
MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQ
PVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR
GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTT
SIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARD
PVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANER
QQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYER
MNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVP
ANTENEGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEV

--------------------------------------------------------------
>In-frame_ENST00000359726_ENST00000369002_TCGA-DJ-A13S-01A_APP_chr21_27252862_-_SEC63_chr6_108214782_length(transcript)=8118nt_BP=3464nt
GGATCAGCTGACTCGCCTGGCTCTGAGCCCCGCCGCCGCGCTCGGGCTCCGTCAGTTTCCTCGGCAGCGGTAGGCGAGAGCACGCGGAGG
AGCGTGCGCGGGGGCCCCGGGAGACGGCGGCGGTGGCGGCGCGGGCAGAGCAAGGACGCGGCGGATCCCACTCGCACAGCAGCGCACTCG
GTGCCCCGCGCAGGGTCGCGATGCTGCCCGGTTTGGCACTGCTCCTGCTGGCCGCCTGGACGGCTCGGGCGCTGGAGGTACCCACTGATG
GTAATGCTGGCCTGCTGGCTGAACCCCAGATTGCCATGTTCTGTGGCAGACTGAACATGCACATGAATGTCCAGAATGGGAAGTGGGATT
CAGATCCATCAGGGACCAAAACCTGCATTGATACCAAGGAAGGCATCCTGCAGTATTGCCAAGAAGTCTACCCTGAACTGCAGATCACCA
ATGTGGTAGAAGCCAACCAACCAGTGACCATCCAGAACTGGTGCAAGCGGGGCCGCAAGCAGTGCAAGACCCATCCCCACTTTGTGATTC
CCTACCGCTGCTTAGTTGGTGAGTTTGTAAGTGATGCCCTTCTCGTTCCTGACAAGTGCAAATTCTTACACCAGGAGAGGATGGATGTTT
GCGAAACTCATCTTCACTGGCACACCGTCGCCAAAGAGACATGCAGTGAGAAGAGTACCAACTTGCATGACTACGGCATGTTGCTGCCCT
GCGGAATTGACAAGTTCCGAGGGGTAGAGTTTGTGTGTTGCCCACTGGCTGAAGAAAGTGACAATGTGGATTCTGCTGATGCGGAGGAGG
ATGACTCGGATGTCTGGTGGGGCGGAGCAGACACAGACTATGCAGATGGGAGTGAAGACAAAGTAGTAGAAGTAGCAGAGGAGGAAGAAG
TGGCTGAGGTGGAAGAAGAAGAAGCCGATGATGACGAGGACGATGAGGATGGTGATGAGGTAGAGGAAGAGGCTGAGGAACCCTACGAAG
AAGCCACAGAGAGAACCACCAGCATTGCCACCACCACCACCACCACCACAGAGTCTGTGGAAGAGGTGGTTCGAGTGTCCCAAAGTTTAC
TCAAGACTACCCAGGAACCTCTTGCCCGAGATCCTGTTAAACTTCCTACAACAGCAGCCAGTACCCCTGATGCCGTTGACAAGTATCTCG
AGACACCTGGGGATGAGAATGAACATGCCCATTTCCAGAAAGCCAAAGAGAGGCTTGAGGCCAAGCACCGAGAGAGAATGTCCCAGGTCA
TGAGAGAATGGGAAGAGGCAGAACGTCAAGCAAAGAACTTGCCTAAAGCTGATAAGAAGGCAGTTATCCAGCATTTCCAGGAGAAAGTGG
AATCTTTGGAACAGGAAGCAGCCAACGAGAGACAGCAGCTGGTGGAGACACACATGGCCAGAGTGGAAGCCATGCTCAATGACCGCCGCC
GCCTGGCCCTGGAGAACTACATCACCGCTCTGCAGGCTGTTCCTCCTCGGCCTCGTCACGTGTTCAATATGCTAAAGAAGTATGTCCGCG
CAGAACAGAAGGACAGACAGCACACCCTAAAGCATTTCGAGCATGTGCGCATGGTGGATCCCAAGAAAGCCGCTCAGATCCGGTCCCAGG
TTATGACACACCTCCGTGTGATTTATGAGCGCATGAATCAGTCTCTCTCCCTGCTCTACAACGTGCCTGCAGTGGCCGAGGAGATTCAGG
ATGAAGTTGATGAGCTGCTTCAGAAAGAGCAAAACTATTCAGATGACGTCTTGGCCAACATGATTAGTGAACCAAGGATCAGTTACGGAA
ACGATGCTCTCATGCCATCTTTGACCGAAACGAAAACCACCGTGGAGCTCCTTCCCGTGAATGGAGAGTTCAGCCTGGACGATCTCCAGC
CGTGGCATTCTTTTGGGGCTGACTCTGTGCCAGCCAACACAGAAAACGAAGTTGAGCCTGTTGATGCCCGCCCTGCTGCCGACCGAGGAC
TGACCACTCGACCAGGTTCTGGGTTGACAAATATCAAGACGGAGGAGATCTCTGAAGTGAAGATGGATGCAGAATTCCGACATGACTCAG
GATATGAAGTTCATCATCAAAAATTGGTGTTCTTTGCAGAAGATGTGGGTTCAAACAAAGGTGCAATCATTGGACTCATGGTGGGCGGTG
TTGTCATAGCGACAGTGATCGTCATCACCTTGGTGATGCTGAAGAAGAAACAGTACACATCCATTCATCATGGTGTGGTGGAGGTTGACG
CCGCTGTCACCCCAGAGGAGCGCCACCTGTCCAAGATGCAGCAGAACGGCTACGAAAATCCAACCTACAAGTTCTTTGAGCAGATGCAGA
ACTAGACCCCCGCCACAGCAGCCTCTGAAGTTGGACAGCAAAACCATTGCTTCACTACCCATCGGTGTCCATTTATAGAATAATGTGGGA
AGAAACAAACCCGTTTTATGATTTACTCATTATCGCCTTTTGACAGCTGTGCTGTAACACAAGTAGATGCCTGAACTTGAATTAATCCAC
ACATCAGTAATGTATTCTATCTCTCTTTACATTTTGGTCTCTATACTACATTATTAATGGGTTTTGTGTACTGTAAAGAATTTAGCTGTA
TCAAACTAGTGCATGAATAGATTCTCTCCTGATTATTTATCACATAGCCCCTTAGCCAGTTGTATATTATTCTTGTGGTTTGTGACCCAA
TTAAGTCCTACTTTACATATGCTTTAAGAATCGATGGGGGATGCTTCATGTGAACGTGGGAGTTCAGCTGCTTCTCTTGCCTAAGTATTC
CTTTCCTGATCACTATGCATTTTAAAGTTAAACATTTTTAAGTATTTCAGATGCTTTAGAGAGATTTTTTTTCCATGACTGCATTTTACT
GTACAGATTGCTGCTTCTGCTATATTTGTGATATAGGAATTAAGAGGATACACACGTTTGTTTCTTCGTGCCTGTTTTATGTGCACACAT
TAGGCATTGAGACTTCAAGCTTTTCTTTTTTTGTCCACGTATCTTTGGGTCTTTGATAAAGAAAAGAATCCCTGTTCATTGTAAGCACTT
TTACGGGGCGGGTGGGGAGGGGTGCTCTGCTGGTCTTCAATTACCAAGAATTCTCCAAAACAATTTTCTGCAGGATGATTGTACAGAATC
ATTGCTTATGACATGATCGCTTTCTACACTGTATTACATAAATAAATTAAATAAAATAACCCCGGGCAAGACTTTTCTTTGAAGGATGAC
TACAGACATTAAATAATCGAAGTAATTTTGGGTGGGGAGAAGAGGCAGATTCAATTTTCTTTAACCAGTCTGAAGTTTCATTTATGATAC
AAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGGATGAGGAAGGCATGCCTGGACAAACCCTTCTTTTAAGATGTGTCTTCAATTTGT
ATAAAATGGTGTTTTCATGTAAATAAATACATTCTTGGAGGAGCTTGGAAGTTCATGAGGCTAAGCCTGTGCCAGAAAATCACCCACAGT
GGGATACAGCAATAGAGGGGGATGAAGACCAGGAGGACAGTGAGGGCTTTGAAGATAGCTTTGAGGAAGAAGAGGAGGAAGAAGAAGATG
ATGACTAAGCAGTACTCTGAATGGACCACAGTGTTTGCACATATTTGCAATTTTTTGCTGTTTTGGAAGTGTATCATAAACCAGAAACAG
TACAGAACTGATGTTGAGGGAGGTGTAGTTTTTTTACTCTTGAAATGGGTGCATAATATAACTAGGCAGTGGCGGTGCCTTGGTACAACC
TGAAAAATGTTAAGGCTTATTGAAACCTTTCAAGTAGGGGATGGTACATTTATTTCATCTGCAAATGATAATAAATCCTTTGTTATTATA
ACTGTCCAGAAGTGTGGGCTATGTATTATCTGATCAGTCTATGGTCCCAGTAAAAGTAAAGATGCAGGAAACACAGTCTGTAAATGAGCG
ACTTTTCTTTGTTCAGCTTTAGTTTTAGCAAACACCACAAATATGTTTTAAGTAACATCGCTCAAGTTTAAGTAACATCGCTCAAGTTGA
TAATCTCTTGATAAGCTCTGTTGTTGACATTTTGCAGTGATACAACAGCTCCACTCATAGATTTAAACTTTTATTTTTACTTATCTTGGT
CATAAGTTGGCATTCTCTCACATTCCACATGATATAGAGGGCTACGTTTTGGAATTTTCCTTTTCTTAATTGCCCAGAGTTATCAGACAG
ATTATAAAAATGGCTTTTAATGGCTTAAACCATTTCTAAACCTCTATCTTAGCAGATCAATGCAGGATCTAATTCTTTTGATAAGTTCTA
GCTCTAAAAGTGATAGTGGGACTGTATGTTTTCTGATACTGGTGGCTTATGTTATTAAACCTTTTTTAAAAAAGGTTCACTCTAAAAGCT
GAACTACATCCTTAGTTTTCAGTCTACTTGACTCTATCAGGAGCTTTTTAAGGAAAGTAAGTATAACATGCAAAGGAAGCTTTTTTTGTA
TTCATTTTGGACTCCTGTCAATAAAAATAGAAGTTTGTTGACTCGTTTTATGTTTCAATGGTGTGTGTCTTTTTACTATCAGGACATAAA
TAGGGCAATCCACTTCTTTATTTTTCAACTAAAGATTGAATAGTATTGTACATTACTGCTAAAGTGACTGCTATTTCTGTATACTGTAGA
AAAACCCAGGAGTGAGAGGGATTTCCCCTCATAGTACAACTGGAAGGATAGTGCTTGTAAAGAGTAGAGATGTGTACATGATGAATCATT
GAGGGAGGGTGGATATTTTTATTCCTAGATATGGAGGAAACATAAGTCTGTAGTATTATAAAACTGATTGTAATAATTCTTTCCTATCAA
AATCTCCATAGGTCAAAATATTGTTGGAATACTAAAATTTGCAACCTTGTTTACTTTAAAAGGTTGCCACTTTCAGTGCAGAATACTACC
GGCATCTTGTTACTGCAATAGTTGGAAATAAAATGTGAAAATTAGCAAAACCATGAATGGTTTTTTTGGTTCTAAATTTAAGATGTAATA
TTTCCTATAAAAGGGTGAAAGCAGTTTCTTTCTCTATAACCTCAATCACCAGTTTAGTGAGAGCCTTTCTTGGCAGGCAGGAGGCAGTGT
CACTGAGGATTTTTTTCATTTACTTCATTGTACAAGTAGGAGGGTGGGTTTAATTTTCAAATCAGGTTCTGCTGTGAAGCACCAGTGTCT
TGAGGCAGCTACTGATTACCTAAGTGTGGTGGCAGGGGGTAAGCCAGCTGGTGTCAAGTGAAAGGAGGGATTAGAGAAAACAGGTGTGGC
ACGAAGGCAAGGAAACTGAGCAGACAAGACAGAACAATGTGTAGAATGCATATTTCCTAGTTTTCTTGAAAGATTTCAAGAAAAGTTGTT
TTTTTTTTTCTAGTGGCTACTTTGCCTTAAAGAGGCTTTATAAGTTCATTCACACAGCTGGCTTCTCTGGTTTTAAGATTCTGGAGAGGA
TGATAACCTAGTAACACCACAGTGCTTAAAAAAAAAAAAAAAAAAAAAACTACCATCACCAGAAAATTCCACCAGTTTGTTTTCCTTTTC
TCTTTGTGTGATGTGTATGTACTTCCCAACTAAGTAAAATAAAATTTCCTCTAGTGAGTGCTTTAGGTAACCTCTTTCCATATGGCAGTA
GTGAAAGAACTGAGCCTTCAGTTGATAGTTCTTCTCTCTCCAGCAAGTCGCTAAACTCCACATCCCTTCGTTTTTCCTCTGGAATGAGAA
TAACAAACTATCCTAGTTTGCATTTAATCTAATGGAAACTTGAGCAAAGTTTCAATTTTCTTCCTATAAAGAAACTGACATTTTGTCAAC
AATTGATGAGCCTATAGATCATACAGTGTATAGGAAGTGAAATTGAAACAGTTAAATTATGTGATATTTTTCTCTAATTGGTAAAGTACC
TATTAAAATACAGCTGTTCATGAGGAGACTTACCACAATTCAAAGTGTAGCAGTTGTGTATTTTAGCATTATAATATTTGATTGAGGCCC
TGAGGTGTTAATATCTCAATCTCAGAGTTAGATGTTCATGTCCTTTTTGAATTTTTTAAACATTTTTCATAATTTTTTTTTTAAGTTAGG
GAGCACATTGAGTGAAGTTCTCTGTGTAGAACAATACCTTCTGCTCTGCTTCTCCCAGCTTTCACTGAGGGCTGGAAAAGGACAGGCCTG
TCCAGCTGTACTGTCCCACTGTGTATGGGGAAGCTCAGGCTCTGGTGGAAGCAGGGGGCGTGGATGTCAAACAACTGATGTGGAAACAGG
GAGGGAGAGATATAATGAGGCTCTCTAGGCATGTTATTTTTGACCACAAGTTTTGTTCAGTTTGCTTCAGCCAATCCAAACCATATACTA
GAGTGTTCTGTAGTCACAATTCTTATTTCAAATGTAATTCAGCACCTTACATAATTTTTGAGAGGTTGTCATTCATCACATATTTACTGA
GTTTCTATGTGCCAGGCTCTGTGACTGGATACTGGAGCTATCAAAATGAAAAAAATAGTGTTAAGAACTCACTCGCTGGTGTTAGAGCAG
GTAGATGAGTGGCAATCCATTTAAATCCATTTGCCTTGGCTATTATTTGGAATGCCTTTTTTTTTTTTTAGTCTATCTACTGTAGGCAGA
AGAATTATTTCTTTAGGGGCTAGCTGTTTATTTTGCTGGCCTTTTTTTCTCTCTTTCTCTTTTTCTTCTTAAGACGGAGTCTCGCTCTGT
CCTCCAGGCTGGAGGAGTGCAGTGGCACGATCTCAGCTCACTGCAACCTCCGCCTCCCAGCTTCAAGCGATTCTTCTGCCTCAGCCTCCT
GAGTAGCTGGGACTGCAGGTGCATGCCACCACACCCAGCTAATTTTTTAATTTTTAGTAGAGATGGGATTTTGCCACGTTGTCCAGCCTG
GTCTCGAACTCCTGGCCTCAAGTGATCAGCCCTCCTCAGCCTCCCAAAGTGCTGGCATTACAGGCATGAGCCACTGCGCCCAGCCTGTTG
GGTTTTTTTGGAAAAAAAACAAAAACAACAAATCATCATCCTTTCCTTTAAAATGTTTTTTTTTTTTTAAGAAACAATTTTCCCACAAAC
GGTCTGATTTAACTCCATGAAATCCTCTATTTAGACTGCCTTAAAGTGAAATAACTGTTGGTGAACCATAACATTTTGCCAGCTGTGTAG
TGATTAGTCCAAATATGTCTCAAGAAGTTAGCACCAAGCATTCTCATCCATTTAAACTTGATGCTAGGGCTATTTTGCAAAACTTAAAAA
GATGCGATCTTGTACATATTTCTGTAACCTGAGCTGAAAACCCAAATAACAATCATTGACATACTTTAGGGCTATTGTTTCAGGTGGGGG
TGTATACATCCCAGGGGCGTGGAGATGATCAATCCATTGAGGAAGTATTAAGATGATTATTTGTATTTAATCTCATCCTTTTAAATTTCT
ATTTTTGTGTGTTTTATAATGTACATAATATATTGTACAATTGTACACTTCTATTATTTATAAATAAACATTTATTGGTGCATTAAGTAG
AGCTGAAGTTTCCTGCACCAGGCAAGCCTGGAAATTATCAGTATACTGTGTTTCTGAGATCAGACTCCTATATGGGTTTGGATCAGATTA
AACCATTGAAGGAAAAACAAGAATGGTGGTGGCTTTACATTGCAGATAGGAAGGAGCAGACATTAATATCCATGCCATATCATGTGTGTA
CGCTGAAAGATACAGAGGAGGAGTGGCAAGAATTACAACAAAGCATACAGCGAAAAGAGAGAGCTCTATTGGAAACCAAATCAAAAATAA
CACATCCTGTGTATAGCCTTTACTTTCCTGAGGAAGCTGCAGTAAAGGAAGATGAAGAAGAAGTTTCAGATAAGGGCAGTGATTCTGAAG
AAGAAGAAACCAATAGAGATTCCCAAAGTGAGAAAGATGATGGTAGTGACAGAGACTCTGATAGAGAGCAAGATGAAAAACAAAACAAAG
ATGATGAAGCAAAAAAAAAAGAAACCTTTAAAAAAAAAACCTACACCTGTGCTATTACCACAGTCAAAGCAACAGAAACAAAAGCAGGCA

>In-frame_ENST00000359726_ENST00000369002_TCGA-DJ-A13S-01A_APP_chr21_27252862_-_SEC63_chr6_108214782_length(amino acids)=714AA_start in transcript=200_stop in transcript=2344
MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQ
PVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR
GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTT
SIATTTTTTTESVEEVVRVSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEA
ERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQ
HTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPS
LTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQ

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for APP-SEC63


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818732_7511144.3333333333333771.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616732_7511069.3333333333333696.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515732_7511013.3333333333334640.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717732_7511125.3333333333333752.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717732_7511126.0753.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717732_7511088.0715.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000346798-1818695_7221144.3333333333333771.0PSEN1
HgeneAPPchr21:27252862chr6:108214782ENST00000348990-1616695_7221069.3333333333333696.0PSEN1
HgeneAPPchr21:27252862chr6:108214782ENST00000354192-1515695_7221013.3333333333334640.0PSEN1
HgeneAPPchr21:27252862chr6:108214782ENST00000357903-1717695_7221125.3333333333333752.0PSEN1
HgeneAPPchr21:27252862chr6:108214782ENST00000358918-1717695_7221126.0753.0PSEN1
HgeneAPPchr21:27252862chr6:108214782ENST00000359726-1717695_7221088.0715.0PSEN1


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117732_7510747.0G(o)-alpha
HgeneAPPchr21:27252862chr6:108214782ENST00000440126-117695_7220747.0PSEN1


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for APP-SEC63


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB03754TromethamineInhibitorSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB06782DimercaprolSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB09148Florbetaben (18F)BinderSmall moleculeApproved
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB14548Zinc sulfate, unspecified formLigandSmall moleculeApproved|Experimental
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB00746DeferoxamineSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01370AluminiumSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB01593ZincCofactorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09130CopperAggregation inhibitorSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09149Florbetapir (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB09151Flutemetamol (18F)BinderSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14517Aluminium phosphateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14518Aluminum acetateSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational
HgeneAPPP05067DB14533Zinc chlorideLigandSmall moleculeApproved|Investigational

Top

Related Diseases for APP-SEC63


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneAPPC0002395Alzheimer's Disease63CTD_human;UNIPROT
HgeneAPPC0011265Presenile dementia35CTD_human
HgeneAPPC0276496Familial Alzheimer Disease (FAD)35CTD_human
HgeneAPPC0494463Alzheimer Disease, Late Onset35CTD_human
HgeneAPPC0546126Acute Confusional Senile Dementia35CTD_human
HgeneAPPC0750900Alzheimer's Disease, Focal Onset35CTD_human
HgeneAPPC0750901Alzheimer Disease, Early Onset35CTD_human
HgeneAPPC0025261Memory Disorders16CTD_human
HgeneAPPC0233794Memory impairment16CTD_human
HgeneAPPC0751292Age-Related Memory Disorders16CTD_human
HgeneAPPC0751293Memory Disorder, Semantic16CTD_human
HgeneAPPC0751294Memory Disorder, Spatial16CTD_human
HgeneAPPC0751295Memory Loss16CTD_human
HgeneAPPC0027746Nerve Degeneration11CTD_human
HgeneAPPC0023186Learning Disorders8CTD_human
HgeneAPPC0751262Adult Learning Disorders8CTD_human
HgeneAPPC0751263Learning Disturbance8CTD_human
HgeneAPPC0751265Learning Disabilities8CTD_human
HgeneAPPC1330966Developmental Academic Disorder8CTD_human
HgeneAPPC2751536CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED7CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneAPPC0009241Cognition Disorders5CTD_human
HgeneAPPC0011570Mental Depression5PSYGENET
HgeneAPPC0011581Depressive disorder5PSYGENET
HgeneAPPC0234544Todd Paralysis5CTD_human
HgeneAPPC0522224Paralysed5CTD_human
HgeneAPPC0497327Dementia3CTD_human;GENOMICS_ENGLAND
HgeneAPPC2931672Cerebral hemorrhage with amyloidosis, hereditary, Dutch type3CTD_human;ORPHANET
HgeneAPPC0270715Degenerative Diseases, Central Nervous System2CTD_human
HgeneAPPC0333463Senile Plaques2CTD_human
HgeneAPPC0524851Neurodegenerative Disorders2CTD_human
HgeneAPPC0600467Neurogenic Inflammation2CTD_human
HgeneAPPC0751733Degenerative Diseases, Spinal Cord2CTD_human
HgeneAPPC2751494CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT2CTD_human
HgeneAPPC2936349Plaque, Amyloid2CTD_human
HgeneAPPC3888307CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT2CTD_human
HgeneAPPC3888308CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT2CTD_human
HgeneAPPC3888309CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT2CTD_human
HgeneAPPC0002622Amnesia1CTD_human
HgeneAPPC0002726Amyloidosis1CTD_human
HgeneAPPC0003469Anxiety Disorders1CTD_human
HgeneAPPC0005586Bipolar Disorder1PSYGENET
HgeneAPPC0006111Brain Diseases1CTD_human
HgeneAPPC0011573Endogenous depression1PSYGENET
HgeneAPPC0016667Fragile X Syndrome1CTD_human
HgeneAPPC0023893Liver Cirrhosis, Experimental1CTD_human
HgeneAPPC0027540Necrosis1CTD_human
HgeneAPPC0033141Cardiomyopathies, Primary1CTD_human
HgeneAPPC0036529Myocardial Diseases, Secondary1CTD_human
HgeneAPPC0036572Seizures1GENOMICS_ENGLAND
HgeneAPPC0037928Spinal Cord Diseases1CTD_human
HgeneAPPC0038002Splenomegaly1CTD_human
HgeneAPPC0038454Cerebrovascular accident1GENOMICS_ENGLAND
HgeneAPPC0043094Weight Gain1CTD_human
HgeneAPPC0085220Cerebral Amyloid Angiopathy1CTD_human
HgeneAPPC0085584Encephalopathies1CTD_human
HgeneAPPC0231341Premature aging syndrome1CTD_human
HgeneAPPC0233750Hysterical amnesia1CTD_human
HgeneAPPC0233796Temporary Amnesia1CTD_human
HgeneAPPC0234985Mental deterioration1CTD_human
HgeneAPPC0236795Dissociative Amnesia1CTD_human
HgeneAPPC0262497Global Amnesia1CTD_human
HgeneAPPC0270612Leukoencephalopathy1GENOMICS_ENGLAND
HgeneAPPC0338582Sporadic Cerebral Amyloid Angiopathy1CTD_human
HgeneAPPC0338630Senile Paranoid Dementia1CTD_human
HgeneAPPC0338656Impaired cognition1CTD_human
HgeneAPPC0376280Anxiety States, Neurotic1CTD_human
HgeneAPPC0553692Brain hemorrhage1GENOMICS_ENGLAND
HgeneAPPC0750906Tactile Amnesia1CTD_human
HgeneAPPC0750907Amnestic State1CTD_human
HgeneAPPC0751071Familial Dementia1CTD_human
HgeneAPPC0751156FRAXA Syndrome1CTD_human
HgeneAPPC0751157FRAXE Syndrome1CTD_human
HgeneAPPC0878544Cardiomyopathies1CTD_human
HgeneAPPC0948008Ischemic stroke1GENOMICS_ENGLAND
HgeneAPPC1270972Mild cognitive disorder1CTD_human
HgeneAPPC1279420Anxiety neurosis (finding)1CTD_human
TgeneSEC63C0158683Polycystic liver disease2CTD_human;ORPHANET
TgeneSEC63C0022680Polycystic Kidney Diseases1CTD_human
TgeneSEC63C1567435Polycystic Kidney - body part1CTD_human
TgeneSEC63C4310769POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS1GENOMICS_ENGLAND